Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: FIH Study of PFLotus in Persistent Atrial Fibrillation [NA]

View source ↗

Summary

A first-in-human study of PFLotus for atrial fibrillation is currently recruiting at The Third People's Hospital of Chengdu.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PFLotus

Snippet

Sponsor: The Third People's Hospital of Chengdu | Conditions: Persistent Atrial Fibrillation | NA | Status: RECRUITING